Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL984514 | 0.87 | GABRA1 (0.41) | GABRA1GABRB2ALDH1A1MAPTCYP2C19 | |
| SCHEMBL10029475 | 0.79 | GABRA1 (0.41) | GABRA1GABRB2ALDH1A1MAPTRIPK1 | |
| SCHEMBL1790386 | 0.79 | ALDH1A1 (0.45) | GABRA1GABRB2ALDH1A1CYP2C19HIF1A | |
| SCHEMBL13462919 | 0.77 | GABRA1 (0.40) | GABRA1GABRB2ALDH1A1MAPTCYP4F2 | |
| SCHEMBL7949339 | 0.77 | GABRA1 (0.39) | GABRA1GABRB2ALDH1A1CYP2C19HIF1A | |
| SCHEMBL1788771 | 0.76 | KCNN4 (0.43) | ALDH1A1MAPTCYP2C19HIF1ARIPK1 | |
| Hydrogen Peroxide SCHEMBL11570368 | 0.74 | GABRA1 (0.50) | GABRA1GABRB2ALDH1A1MAPTPOLB | |
| SCHEMBL12262668 | 0.74 | GABRA1 (0.50) | GABRA1GABRB2ALDH1A1MAPTCYP2C19 | |
| SCHEMBL16105766 | 0.73 | GABRA1 (0.48) | GABRA1GABRB2ALDH1A1MAPTCYP2D6 | |
| SCHEMBL1521882 | 0.73 | GABRA1 (0.48) | GABRA1GABRB2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2275405-B1 | PROCESS FOR PRODUCING ISOCYANATE USING DIARYL CARBONATE | ASAHI CHEMICAL IND (JP) | 2019-04-24 | — | — | EP | disclosed |
| EP-2275406-B1 | PROCESS FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2018-11-28 | — | — | EP | disclosed |
| US-9233918-B2 | Isocyanate production process | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| US-8895774-B2 | Process for producing isocyanates using diaryl carbonate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-11-25 | — | — | US | disclosed |
| US-20110092731-A1 | ISOCYANATE PRODUCTION PROCESS | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-20110054211-A1 | PROCESS FOR PRODUCING ISOCYANATES USING DIARYL CARBONATE | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-03-03 | — | — | US | disclosed |
| EP-2275406-A1 | PROCESS FOR PRODUCING ISOCYANATE | Asahi Kasei Chemicals Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
| EP-2275405-A1 | PROCESS FOR PRODUCING ISOCYANATE USING DIARYL CARBONATE | Asahi Kasei Chemicals Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-6197918-B1 | INTERCHANGE REACTION OF DIALKYL CARBONATE AND AROMATIC ALCOHOL; CATALYSIS WITH TITANIUM HALIDE, ALKOXIDE, ARYLOXIDE, OR ACETOXIDE | GENERAL ELECTRIC COMPANY | 2001-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110092731-A1 | ISOCYANATE PRODUCTION PROCESS | CPS1, PHGDH, APEH | GABRA1 4305/4885GABRB2 3761/4885ALDH1A1 2204/4885 |
| US-20110054211-A1 | PROCESS FOR PRODUCING ISOCYANATES USING DIARYL CARBONATE | PAH, AADAC, PHGDH | GABRA1 4570/4885GABRB2 4527/4885ALDH1A1 3223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.